Search research articles
Contact Us
Filters
Showing results (121-130 of 186) with videos related to
Page
of 19
Sort By:
Journal of Medicinal Chemistry
|
February 18, 2005
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists
F Ivy Carroll, Wei Ma, Yasuno Yokota, et al.
The International Journal of Neuropsychopharmacology
|
October 16, 2019
Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats
Sarah Page, Maria M Mavrikaki, Tania Lintz, et al.
Bioorganic & Medicinal Chemistry
|
August 3, 2015
Synthesis, nicotinic acetylcholine receptor binding, in vitro and in vivo pharmacology properties of 3'-(substituted pyridinyl)-deschloroepibatidine analogs
Pauline W Ondachi, Zhuo Ye, Ana H Castro, et al.
Biochemistry
|
May 21, 2003
Reversing the action of noncompetitive inhibitors (MK-801 and cocaine) on a protein (nicotinic acetylcholine receptor)-mediated reaction
George P Hess, Armanda M Gameiro, Ryan C Schoenfeld, et al.
Psychopharmacology
|
April 2, 2010
Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
Christina L Nemeth, Tracie A Paine, Joseph E Rittiner, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 26, 2004
Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging
Kimberly P Lindsey, Kristin M Wilcox, John R Votaw, et al.
Journal of Psychopharmacology (Oxford, England)
|
November 2, 2022
Pharmacological characterization of 5-iodo-A-85380, a β2-selective nicotinic receptor agonist, in mice
Lois S Akinola, Deniz Bagdas, Yasmin Alkhlaif, et al.
Molecular Pharmacology
|
August 24, 2004
Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors
M Imad Damaj, F Ivy Carroll, J Brek Eaton, et al.
Journal of Medicinal Chemistry
|
January 9, 2004
Discovery of the first N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphan to possess highly potent and selective opioid delta receptor antagonist activity
F Ivy Carroll, Li Zhang, S Wayne Mascarella, et al.
Journal of Medicinal Chemistry
|
October 23, 2013
4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist
F Ivy Carroll, Moses G Gichinga, John D Williams, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 186) with videos related to
Sort By:
Page
of 19
Journal of Medicinal Chemistry
|
February 18, 2005
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists
F Ivy Carroll, Wei Ma, Yasuno Yokota, et al.
The International Journal of Neuropsychopharmacology
|
October 16, 2019
Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats
Sarah Page, Maria M Mavrikaki, Tania Lintz, et al.
Bioorganic & Medicinal Chemistry
|
August 3, 2015
Synthesis, nicotinic acetylcholine receptor binding, in vitro and in vivo pharmacology properties of 3'-(substituted pyridinyl)-deschloroepibatidine analogs
Pauline W Ondachi, Zhuo Ye, Ana H Castro, et al.
Biochemistry
|
May 21, 2003
Reversing the action of noncompetitive inhibitors (MK-801 and cocaine) on a protein (nicotinic acetylcholine receptor)-mediated reaction
George P Hess, Armanda M Gameiro, Ryan C Schoenfeld, et al.
Psychopharmacology
|
April 2, 2010
Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
Christina L Nemeth, Tracie A Paine, Joseph E Rittiner, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 26, 2004
Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging
Kimberly P Lindsey, Kristin M Wilcox, John R Votaw, et al.
Journal of Psychopharmacology (Oxford, England)
|
November 2, 2022
Pharmacological characterization of 5-iodo-A-85380, a β2-selective nicotinic receptor agonist, in mice
Lois S Akinola, Deniz Bagdas, Yasmin Alkhlaif, et al.
Molecular Pharmacology
|
August 24, 2004
Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors
M Imad Damaj, F Ivy Carroll, J Brek Eaton, et al.
Journal of Medicinal Chemistry
|
January 9, 2004
Discovery of the first N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphan to possess highly potent and selective opioid delta receptor antagonist activity
F Ivy Carroll, Li Zhang, S Wayne Mascarella, et al.
Journal of Medicinal Chemistry
|
October 23, 2013
4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist
F Ivy Carroll, Moses G Gichinga, John D Williams, et al.
Page
of 19